Dean A. Lee

Division of Pediatrics, MD Anderson Cancer Center - University of Texas

Affiliated withMD Anderson Cancer Center - University of Texas Nationwide Children's Hospital

Research Area

Biography

Dean A. Lee has not added Biography.
If you are Dean A. Lee and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 153	2011
Publication title Cited by 55	2018

Other Publications

Article	Year
Activated peripheral T lymphocytes undergo apoptosis when cultured with monocytes activated by HLA class II ligation. Cellular immunology\| PubMed ID: 14698144	2003
Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity\| PubMed ID: 14738769	2004
Granulocytic sarcoma presenting as pneumonia in a child with t(8;21) acute myelogenous leukemia: diagnosis by fluorescent in situ hybridization. Journal of pediatric hematology/oncology\| PubMed ID: 15218417	2004
Rotavirus vaccines. The New England journal of medicine\| PubMed ID: 16625014	2006
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH. Pediatric blood & cancer\| PubMed ID: 17243127	2008
C/EBPbeta suppression by interruption of CUGBP1 resulting from a complex rearrangement of MLL. Cancer genetics and cytogenetics\| PubMed ID: 17854664	2007
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Human gene therapy\| PubMed ID: 19905893	2010
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies. Cancer research\| PubMed ID: 20424114	2010
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells. Biomedical microdevices\| PubMed ID: 20574820	2010
Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapy. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 20686960	2010
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer research\| PubMed ID: 21558388	2011
Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies. Human gene therapy\| PubMed ID: 22107246	2012
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells. PloS one\| PubMed ID: 22279576	2012
NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation. Immunotherapy\| PubMed ID: 22329587	2012
Natural killer cells in malignant hematology: A primer for the non-immunologist. Blood reviews\| PubMed ID: 27665023	2017
The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3. Scientific reports\| PubMed ID: 28338101	2017
Interferon Gamma Induces Changes in Natural Killer (NK) Cell Ligand Expression and Alters NK Cell-Mediated Lysis of Pediatric Cancer Cell Lines. Frontiers in immunology\| PubMed ID: 28428785	2017
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation. Molecular immunology\| PubMed ID: 28644973	2017
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. Breast cancer research : BCR\| PubMed ID: 28668076	2017
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation. Blood\| PubMed ID: 28835441	2017
Venous Thromboembolism in Pediatric Hematopoietic Cell Transplant: A Multicenter Cohort Study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 29128552	2018
Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 29189387	2018
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. Journal for immunotherapy of cancer\| PubMed ID: 29254507	2017
Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells. Cancer immunology, immunotherapy : CII\| PubMed ID: 29299659	2018
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PloS one\| PubMed ID: 29342200	2018
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nature communications\| PubMed ID: 29674644	2018